214 related articles for article (PubMed ID: 27943368)
1. Rapid and durable response to intravenous immunoglobulin in delayed heparin-induced thrombocytopenia: a case report.
Lei BZ; Shatzel JJ; Sendowski M
Transfusion; 2017 Apr; 57(4):919-923. PubMed ID: 27943368
[TBL] [Abstract][Full Text] [Related]
2. A journey through anticoagulant therapies in the treatment of left ventricular thrombus in post-COVID-19 heparin-induced thrombocytopenia: a case report.
Lázaro-García A; Martínez-Alfonzo I; Vidal-Laso R; Velasco-Rodríguez D; Tomás-Mallebrera M; González-Rodríguez M; Llamas-Sillero P
Hematology; 2022 Dec; 27(1):318-321. PubMed ID: 35231200
[TBL] [Abstract][Full Text] [Related]
3. High-dose intravenous immunoglobulin to treat spontaneous heparin-induced thrombocytopenia syndrome.
Mohanty E; Nazir S; Sheppard JI; Forman DA; Warkentin TE
J Thromb Haemost; 2019 May; 17(5):841-844. PubMed ID: 30773806
[TBL] [Abstract][Full Text] [Related]
4. Intravenous warfarin and heparin-induced thrombocytopenia: making the diagnosis, management, modern monitoring, and multidisciplinary care.
Burger CF; Schlesinger JJ
Ann Pharmacother; 2014 Feb; 48(2):286-91. PubMed ID: 24259642
[TBL] [Abstract][Full Text] [Related]
5. Heparin-induced thrombocytopenia: treatment options and special considerations.
Dager WE; Dougherty JA; Nguyen PH; Militello MA; Smythe MA
Pharmacotherapy; 2007 Apr; 27(4):564-87. PubMed ID: 17381384
[TBL] [Abstract][Full Text] [Related]
6. Alternative anticoagulation during cardiovascular procedures in pediatric patients with heparin-induced thrombocytopenia.
Argueta-Morales IR; Olsen MC; DeCampli WM; Munro HM; Felix DE
J Extra Corpor Technol; 2012 Jun; 44(2):69-74. PubMed ID: 22893986
[TBL] [Abstract][Full Text] [Related]
7. Heparin-induced thrombocytopenia and cardiac surgery.
Levy JH; Winkler AM
Curr Opin Anaesthesiol; 2010 Feb; 23(1):74-9. PubMed ID: 19996742
[TBL] [Abstract][Full Text] [Related]
8. Argatroban and bivalirudin compared to unfractionated heparin in preventing thrombus formation on mechanical heart valves. Results of an in-vitro study.
Maegdefessel L; Linde T; Michel T; Hamilton K; Steinseifer U; Friedrich I; Schubert S; Hauroeder B; Raaz U; Buerke M; Werdan K; Schlitt A
Thromb Haemost; 2009 Jun; 101(6):1163-9. PubMed ID: 19492162
[TBL] [Abstract][Full Text] [Related]
9. A randomized, open-label pilot study comparing desirudin and argatroban in patients with suspected heparin-induced thrombocytopenia with or without thrombosis: PREVENT-HIT Study.
Boyce SW; Bandyk DF; Bartholomew JR; Frame JN; Rice L
Am J Ther; 2011 Jan; 18(1):14-22. PubMed ID: 21079512
[TBL] [Abstract][Full Text] [Related]
10. Heparin-induced thrombocytopenia: when a low platelet count is a mandate for anticoagulation.
Ortel TL
Hematology Am Soc Hematol Educ Program; 2009; ():225-32. PubMed ID: 20008202
[TBL] [Abstract][Full Text] [Related]
11. Successful use of a bivalirudin treatment protocol to prevent extracorporeal thrombosis in ambulatory hemodialysis patients with heparin-induced thrombocytopenia.
Al-Ali FS; Elsayed M; Khalifa S; Abdulla AE; Tolba H; Bouanane H; Ibrahim R; Hamad A
Hemodial Int; 2016 Apr; 20(2):204-7. PubMed ID: 26501237
[TBL] [Abstract][Full Text] [Related]
12. Direct thrombin inhibition during percutaneous coronary intervention in patients with heparin-induced thrombocytopenia.
Lewis BE; Hursting MJ
Expert Rev Cardiovasc Ther; 2007 Jan; 5(1):57-68. PubMed ID: 17187457
[TBL] [Abstract][Full Text] [Related]
13. Recognition of heparin-induced thrombocytopenia and initiation of argatroban therapy after cardiothoracic surgery in the intensive care unit.
Demma LJ; Paciullo CA; Levy JH
J Thorac Cardiovasc Surg; 2012 May; 143(5):1213-8. PubMed ID: 22329977
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of treatment with direct thrombin inhibitors in patients with heparin-induced thrombocytopenia.
Dang CH; Durkalski VL; Nappi JM
Pharmacotherapy; 2006 Apr; 26(4):461-8. PubMed ID: 16553503
[TBL] [Abstract][Full Text] [Related]
15. Heparin-induced thrombocytopenia. A contemporary clinical approach to diagnosis and management.
Shantsila E; Lip GYH; Chong BH
Chest; 2009 Jun; 135(6):1651-1664. PubMed ID: 19497901
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of diagnostic tests and argatroban or lepirudin therapy in patients with suspected heparin-induced thrombocytopenia.
Kiser TH; Jung R; MacLaren R; Fish DN
Pharmacotherapy; 2005 Dec; 25(12):1736-45. PubMed ID: 16305293
[TBL] [Abstract][Full Text] [Related]
17. Practical viewpoints on the diagnosis and management of heparin-induced thrombocytopenia.
Lassila R; Antovic JP; Armstrong E; Baghaei F; Dalsgaard-Nielsen J; Hillarp A; Holme PA; Holmström M; Johnsson H; Joutsi-Korhonen L; Sandset PM
Semin Thromb Hemost; 2011 Apr; 37(3):328-36. PubMed ID: 21455867
[TBL] [Abstract][Full Text] [Related]
18. Use of systemic bivalirudin with catheter-directed thrombolysis in a patient with heparin-induced thrombocytopenia: A case report.
Badreldin HA; Rimsans J; Connors JM; Wiviott SD
Catheter Cardiovasc Interv; 2018 Feb; 91(3):E17-E20. PubMed ID: 29068112
[TBL] [Abstract][Full Text] [Related]
19. Alternative anticoagulation management strategies for the patient with heparin-induced thrombocytopenia undergoing cardiac surgery.
Murphy GS; Marymont JH
J Cardiothorac Vasc Anesth; 2007 Feb; 21(1):113-26. PubMed ID: 17289495
[No Abstract] [Full Text] [Related]
20. Autoimmune heparin-induced thrombocytopenia and venous limb gangrene after aortic dissection repair: in vitro and in vivo effects of intravenous immunoglobulin.
Arcinas LA; Manji RA; Hrymak C; Dao V; Sheppard JI; Warkentin TE
Transfusion; 2019 Jun; 59(6):1924-1933. PubMed ID: 30903805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
